Bristol-Myers Squibb
BMY
2,259 hedge funds and large institutions have $80B invested in Bristol-Myers Squibb in 2024 Q3 according to their latest regulatory filings, with 266 funds opening new positions, 820 increasing their positions, 929 reducing their positions, and 130 closing their positions.
105% more first-time investments, than exits
New positions opened: 266 | Existing positions closed: 130
50% more funds holding in top 10
Funds holding in top 10: 18 → 27 (+9)
25% more capital invested
Capital invested by funds: $63.8B → $80B (+$16.2B)
5% more funds holding
Funds holding: 2,148 → 2,259 (+111)
0.63% more ownership
Funds ownership: 75.77% → 76.4% (+0.63%)
5% less call options, than puts
Call options by funds: $1.88B | Put options by funds: $1.99B
12% less repeat investments, than reductions
Existing positions increased: 820 | Existing positions reduced: 929
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of New York Mellon
New York
|
+$331M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$232M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$201M |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$186M |
| 5 |
Millennium Management
New York
|
+$173M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital International Investors
Los Angeles,
California
|
-$599M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$276M |
| 3 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$220M |
| 4 |
SOMRS
State of Michigan Retirement System
Lansing,
Michigan
|
-$190M |
| 5 |
Squarepoint
New York
|
-$184M |
BMY Hedge Fund Activity: Q3 2024 in Review
2,259 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Bristol-Myers Squibb (BMY) for Q3 2024, worth a combined $80B — up 25% from $63.8B a quarter earlier.
Buyers outnumbered sellers: 266 funds opened new BMY positions and 130 closed out — a net gain of 136 holders — while 820 added to existing stakes and 929 trimmed.
The largest buyer was Bank of New York Mellon, adding an estimated $331M. The largest seller was Capital International Investors, cutting an estimated $599M.
- 2,259 institutional investors held Bristol-Myers Squibb (BMY) as of Q3 2024, up from 2,148 in Q2 2024.
- Funds reported $80B of Bristol-Myers Squibb stock for Q3 2024, up 25% quarter-over-quarter.
- 266 funds opened new Bristol-Myers Squibb positions in Q3 2024 and 130 closed out, a net change of +136 holders.
- The largest Bristol-Myers Squibb buyer in Q3 2024 was Bank of New York Mellon, an estimated $331M added.
- The largest Bristol-Myers Squibb seller in Q3 2024 was Capital International Investors, an estimated $599M sold.
Based on aggregated 13F filings for Q3 2024.